Climb Bio News

Climb Bio | S-3: Registration statement for specified transactions by certain issuers

Nov 13 05:55

8-K: Current report

Oct 15 19:09

Eliem Therapeutics | 8-K: Current report

Oct 3 04:20

Eliem Therapeutics | 8-K: Current report

Aug 28 05:25

Eliem Therapeutics | 8-K: Current report

Aug 26 19:11

Eliem Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Jul 13 04:18

Eliem Therapeutics | 8-K: Current report

Jun 28 04:28

Eliem Therapeutics | 8-K: Current report

Jun 27 04:28

Eliem Therapeutics | DEFA14A: Others

Jun 15 05:07

Eliem Therapeutics | DEFA14A: Others

Jun 13 04:47

Eliem Therapeutics | 8-K: Current report

Jun 13 04:43

Eliem Therapeutics | DEFM14A: Definitive proxy statement relating to merger or acquisition

Jun 4 20:02

Eliem Therapeutics | DEFA14A: Others

Apr 11 20:14

Eliem Therapeutics | 8-K: Current report

Apr 11 20:04

Eliem Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 29 04:35

Eliem Therapeutics | 8-K: Current report

Mar 20 01:33

Eliem Therapeutics | 8-K: Current report

Jul 20, 2023 18:55

Eliem Therapeutics | 8-K: Current report

May 20, 2023 04:45

Eliem Therapeutics | DEFA14A: Others

Apr 7, 2023 04:10

Eliem Therapeutics | DEF 14A: Definitive proxy statements

Apr 7, 2023 04:05